All the information on this page has been produced in partnership with James Pendle, Olivier Sluijters and Adam Williams at NBT.
The neurosurgical department at NBT is a tertiary referral unit and therefore does not usually accept referrals directly from GPs. However, there is access to certain neurosurgery clinics via eReferral and these are described in the directory of services of eRS. Please note that many of these clinics are Referral Assessment Services (RAS) so referrals may be returned to referrer if not appropriate.
Patients with suspected cranial or spinal trauma should usually be referred to the local Accident and Emergency Department for imaging prior to onward referral if necessary.
Patients with suspected cancer should be referred via the Brain and CNS – USC (2WW) pathway.
Post Operative Concerns - If you have acute concerns about a patient who has recently had a neurosurgical procedure and you require a same-day response, please refer urgently to our on-call via Refer-a-Patient.
If you do not require same day advice, please contact the patient’s surgical team. These details should be available on their recent clinic / discharge letters.
Patients for other neurosurgical procedures will normally be referred from other secondary care specialties or MSK Interface Service.
The referral pathways for neurosurgical services are broadly split into 3.
Please visit the Neurosurgery Remedy pages within the for the relevant condition for information and guidance on pathways.
Links to NBT Services
Bristol Neuro-oncology Group
Neurosurgery MDT Referral to Multidisciplinary Team Meetings (MDT) at North Bristol Trust
Neuro-oncology (BNOG) Referrals
Head Injury Therapy Unit (HITU) On-call referrals: https://www.referapatient.org/refer-a-patient
ERS referrals: LINK?
GIRFT guidance: Spinal – Suspected Cauda Equina Syndrome 2a - GIRFT - Pathways
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.